“…Recently, applications of new transition metal complexes and nanomaterials such as quantum dots, layered composites, and two-dimensional metal–organic frameworks have been explored in the fields of electrocatalysts, photocatalysts, sensors, energy storage, optoelectronic devices, superconductors, medicine, and medical treatment. , Various transition metal complexes reveal the therapeutic potential to treat cancer, inflammation, neurological disease, and diabetes. , In addition, transition metal carbides could be used in tumor therapy according to their photothermal conversion performance and tumor imaging as a contrast agent . The ruthenium complexes have attracted more attention in recent years due to low toxicity and high stability. , Ruthenium is an inert metal of the platinum group, which has therapeutic properties similar to platinum. , For instance, ruthenium–quinoline complexes, including TQ-1, TQ-2, TQ-4, and TQ-6, were synthesized using Li et al’s method ,− and demonstrated significant anti-inflammatory activity . Although ruthenium complexes have substantial therapeutic effects, they have limits for clinical usage, such as dose-dependent side effects and a short circulation time.…”